000			01560 a2200445 4500
005			20250515065253.0
264		0	_c20070621
008			200706s 0 0 eng d
022			_a1559-7768
024	7		_a10.4037/15597768-2007-2006 _2doi
040			_aNLM _beng _cNLM
100	1		_aRose, Louise
245	0	0	_aRecombinant factor VIIa: review of current "off license" indications and implications for practice. _h[electronic resource]
260			_bAACN advanced critical care _c
300			_a141-8 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aCardiac Surgical Procedures _xadverse effects
650	0	4	_aCritical Care _xmethods
650	0	4	_aDrug Labeling
650	0	4	_aDrug Monitoring
650	0	4	_aDrug and Narcotic Control
650	0	4	_aErythrocyte Transfusion
650	0	4	_aEvidence-Based Medicine
650	0	4	_aFactor VII _xpharmacology
650	0	4	_aFactor VIIa
650	0	4	_aHemorrhage _xdrug therapy
650	0	4	_aHospital Mortality
650	0	4	_aHumans
650	0	4	_aLiver Failure _xcomplications
650	0	4	_aNurse's Role
650	0	4	_aPatient Selection
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRecombinant Proteins _xpharmacology
650	0	4	_aSafety
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States _xepidemiology
650	0	4	_aWounds and Injuries _xcomplications
773	0		_tAACN advanced critical care _gvol. 18 _gno. 2 _gp. 141-8
856	4	0	_uhttps://doi.org/10.4037/15597768-2007-2006 _zAvailable from publisher's website
999			_c17021408 _d17021408